Meanwhile, 357,719 people received their first dose of covid-19 vaccine in the same period, bringing the number of people who are at least partially vaccinated against covid-19 to 151,775,597.
To achieve herd immunity, the Indonesian government plans to vaccinate more than 200 million people.
Covovax
Last week, the World Health Organization (WHO) issued an emergency use listing (EUL) for NVX-CoV2373, expanding the basket of WHO-validated vaccines against the SARS-CoV-2 virus.The vaccine, named CovovaxTM, is produced by the Serum Institute of India under licence from Novavax and is part of the COVAX facility portfolio.
CovovaxTM is a subunit of the vaccine developed by Novavax and the Coalition for Epidemic Preparedness Innovations (CEPI). It requires two doses and is stable at 2 to 8 °C refrigerated temperatures. The vaccine uses a novel platform and is produced by creating an engineered baculovirus containing a gene for a modified SARS-CoV-2 spike protein.
Cek Berita dan Artikel yang lain di Google News
